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INTRODUCTION 
 Cardiac disease is a major risk factor for stroke, ranking third after age 
and hypertension.1  Congestive Cardiac failure ranks second in cardiogenic 
stroke risk 1, with a two fold to three fold relative risk1,2. The prevalence of 
cardiac failure increases substantially in prevalence as the population ages. 
Cardiac failure is also associated with high mortality, with a 15 year total 
mortality rate estimated at 39% for women and 72% for men3. 
 LVSD is common and treatable, accounting for 8%of people aged 25-
75 years and 12% of 45-75 years. Of the 8% ,4% are asymptomatic6. The 
patients who appear to be at high risk of LVSD are those with ischaemic heart 
disease, hypertension   or diabetes, and smokers9-11. However, 
echocardiographic screening of all hypertensives, all diabetics and all smoker 
for LVSD would be a daunting and costly process.  A more cost- effective 
approach might be to wait for the first presentation of a vascular episode, and 
to perform routine echo screening  at that time. The first vascular episode  
could be either a myocardial  infarction  (MI), a  transient ischaemic attack 
(TIA), a cerebro vascular accident  or peripheral vascular  disease.  In normal 
clinical  practice , MI patients are now a days screened for LVSD  during their 
hospital  admission, but, patients who have had CVA/ TIA/ PVD are not 
routinely screened for LVSD . Yet, the presentation with one vascular episode 
in the form  of stroke could be a golden opportunity to detect and treat LVSD, 
and  thereby  reduce the subsequent incidence of overt heart failure, and 
perhaps even sudden cardiac death. 
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 We are aware that LVDD is also a major risk factor contributing 
towards mortality especially in hypertensives and elders. It is in this context,  
I have tried to assess LV function in patients who presented with 
atherothrombotic stroke. 
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REVIEW OF LITERATURE 
DEFINITION  
 Stroke or cerebro  vascular accident is a rapidly developing clinical 
symptom  and /or signs of  focal, and at times global (applied to patients  in 
deep coma and to those with sub arachnoid  haemorrhage) loss  of cerebral 
function  with symptoms lasting  more than 48 hrs or leading  to death with no 
apparent  cause other than that of vascular origin. 
 Cerebral infarction accounts for approximately 80%  of the stroke as 
opposed to  10% due to primary intracerebral bleed, 5% due to subarachnoid 
haemorrhage and another 5% of uncertain etiology4. 
ATHEROSCLEROSIS AND STROKE  
 Stroke can affect a person at any age. Still, advancing age is the single 
most important factor that predicts an increased likelihood of ischemic  
stroke. Risks increase rapidly after the age of 55 in both men and women of 
all ethnic groups12-15. The risks of stroke approximately double with every 10- 
years increase in age. Ischemic stroke is a leading cause  of acute- onset 
neurological  impairments among persons older than 55, and stroke should be 
a leading consideration to explain new neurological symptoms in this 
population. Atherosclerosis and ischemic heart disease are  the primary  
substrates  for ischemic stroke in this age group. The formation of 
atherosclerotic plaques and the development of arterial stenoses increase with 
advancing age16,17. Still, the influence of well –recognized risk factors 
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(hypertension, smoking, etc.) on the development of advanced  atherosclerotic 
lesions is not as great in the elderly as among young persons.16 Some of the 
lack of an association  between the traditional atherosclerotic risk factors and 
stroke in older  persons with the highest risk. 
HYPERTENSION AND STROKE  
 Hypertension is calculated to be a factor in 70% of strokes and among 
survivors, it identifies a patient as having an increased risk of a second 
event18-21.  The risk of stroke increases 10-12 times if diastolic blood pressure 
is 105mm Hg in comparison to a normal diastolic blood pressure of 
approximately 76mm Hg8,22. Overall, arterial hypertension increases the 
likelihood of stroke.  The risk rises rapidly with higher levels of blood 
pressure22.  The impact of an increase in diastolic blood pressure is much 
greater in young adults than in the elderly.  Although elevated diastolic blood 
pressure is a usual marker for hypertension, isolated systolic hypertension 
also predicts stroke in elderly persons22,23.  Isolated systolic hypertension also 
is correlated with increased thickness and plaque formation of the internal 
carotid artery.  Both elevated diastolic and systolic blood pressure are 
associated with increased concentrations of hemoglobin, which is a risk factor 
for ischemic stroke24. 
 Chronic hypertension promotes the development of both large and 
medium caliber artery atherosclerosis and the lipohyalinosis of small 
penetrating arteries of the brain25.  The vascular endothelium is the central 
focus of the effects of hypertension that promotes turbulence at the site of an 
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atherosclerotic plaque.  Because hypertension leads to coronary artery disease, 
cardiomyopathy, and atrial fibrillation, it is an indirect risk factor for stroke 
secondary to cardioembolism.  Reducing diastolic blood pressure by 
approximately 5mm Hg can reduce the incidence of an mortality from stroke 
by 42% and 30% respectively26,27.  In elderly patients, a drop of systolic blood 
pressure by approximately 11mm Hg can lead to a 30% decline in the 
frequency of stroke.  A report from Asia concluded that a population-wide 
reduction of 3mm Hg in diastolic blood pressure could reduce the number of 
strokes by one-third28.  The optimal levels for blood pressure are 80-85mm 
Hg diastolic and 130-140mm HG systolic.   
DIABETES MELLITUS AND STROKE  
 Persons with either type I or type II diabetes mellitus have an increased 
susceptibility for larger artery atherosclerosis and small artery occlusive 
disease.   Although glucose intolerance is accompanied by arterial disease, it 
may not be associated with an increased risk of stroke.  In contrast, diabetic 
patients often have elevated levels of triglycerides or high-density 
lipoproteins that persist even with control of the hyperglycemia29.  Diabetes 
mellitus also leads to renal or cardiac disease, which indirectly promote 
arterial hypertension and stroke.   Autonomic disturbances secondary to 
diabetic neuropathy also may play a role by causing hypotension .  Diabetes 
also increases level of fibrinogen; and clotting factors increase platelet 
aggregation,  which in turn promotes arterial thrombosis.  
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ELEVATED BLOOD LIPIDS AND STROKE  
 The incidence of coronary artery disease and atherosclerosis of major 
intracranial or extracranial arteries increases with rising levels of serum 
cholesterol.  Recent data show that hyper-cholesterolemia is a key risk factor 
for ischemic stroke, especially in men under the age of 60.  Hyperlipidemia 
causes a modest increase in risk of stroke in persons older than 62.  Some of 
the risk may be indirect, due to the potent effects of hyperlipidemia on 
coronary artery disease, leading to myocardial infarction and cardioembolism. 
Sequential duplex ultrasound studies of the carotid arteries demonstrate that 
hypercholesterolemia accelerates the course of early atherosclerotic lesions 
(intimal-medial thickness [IMT]) 30.   
HEART DISEASE AND  STROKE  
 Heart disease is a  leading  potential  cause of ischemic neurological  
symptoms. In  addition to  causing ischemic  stroke  secondary  to 
cardioembolism,  heart disease also produces recurrent  neurological  
complaints that  are  included in the  differential  diagnosis  of transient  
ischemic  attack (TIA). Intermittent  cardiac arrhythmias,  most commonly  
intermittent  complete heart block  or the bradycardia - tachycardia (sick sinus   
syndrome),  are frequent  cardiac cause  of  recurrent  syncope  in the  elderly.  
Cardioembolism accounts for approximately 20% - 25% of ischemic strokes 
and  is  a leading  cause  of stroke  in persons  of all ages. Emboli from the  
heart  can  go  to  any  intracranial  artery. Both proximal and distal 
intracranial  arterial occlusions can develop. As  a  result,  cardioembolism  
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should be  considered  in the  differential  diagnosis for  cause  of symptoms 
in any  patient with  a TIA or an ischemic stroke in either the carotid  or the 
vertebrobasilar  circulation31,32. The  types  of heart disease  leading to  stroke 
also varies by age;  coronary  artery disease and atrial fibrillation are  leading 
etiologies   in  persons older  than  45, whereas valvular  diseases are more  
prominent in  younger  persons. Because symptomatic coronary artery disease 
appears at earlier ages in men, it  is  a leading   substrate for  cardioembolic 
stroke  in middle-age  men. Conversely,  atrial fibrillation is  a leading  cause 
of   stroke  in women,  especially  in those  older than  75. Most  patients  with  
cardioembolic stroke  have  a prior   history of  heart disease. Still, stroke can 
be  a first presentation  of otherwise occult heart disease. In  general, patients 
have  cardiac symptoms, including  chest pain,  fatigue,  or dyspnea,  and 
clinical  evidence  of  heart  disease, such as a murmur,  cardiomegaly, 
cyanosis,  or  peripheral edema. Patients also  may have  been treated with  
cardiovascular  medications  or cardiac procedures.  A past history  of an 
abnormal chest  x-ray or electrocardiogram also  might suggest structural 
heart  disease.  
CARDIAC DYSRHYTHMIAS  AND STROKE  
 The two abnormalities of cardiac rhythm most often associated with 
focal cerebral ischemia are  atrial fibrillation  and the sick sinus  syndrome.  
 Diffuse nonfocal cerebral ischemia  (i.e., syncope or Stokes- Adams  
attacks) may  be caused by cardiac dysrhythmias that  induce cerebral 
hypoperfusion. Reduction in cerebral perfusion  is  usually the   result of 
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complete heart  block  or paroxysmal  tachyarrhythmia  associated  with a  
rapid  ventricular  rate of  more  than 180  beats per minute (e.g., paroxysmal 
atrial tachycardia,  ventricular tachycardia, or  ventricular   fibrillation). Focal  
cerebral ischemia  is rare  with such  distrubances of  cardiac rhythm.  
ATRIAL FIBRILLATION  AND  STROKE  
 Nonvalvular atrial fibrillation (NVAF) is   the term commonly  used to  
specify  the group  of patients in which  the underlying cause is other  than 
valvular disease. NVAF affects 2% to 5%  of the general population over the 
age  of  60.  Atrial  fibrillation  is the most  common  cardiac  abnormality 
correlated with  embolic stroke. The  arrhythmia appears  to predispose  
thromboembolism  by reducing the  contraction  of  the left atrium,  
decreasing  flow  in the  left  atrial appendage, increasing  turbulence in the   
left  atrium, and  leading to enlargement  of  the left  atrium and left  atrial 
appendage33. All  of these factors promote  stasis and  the formation of  clots  
with in the  left atrium. It is not clear whether atrial fibrillation  is the cause  
or  a  complication   of dilation of the  left atrium. The  risk of  embolism  in 
patients  with  the arrhythmia  is increased by  the presence of  structural  
heart disease. Conversely,  the risk  of embolism  from structural heart disease 
is  increased  by the presence of  atrial  fibrillation. For example, the  presence 
of atrial  fibrillation  after myocardial  infarction greatly  increases the risk  of  
stroke.  The  finding  of atrial fibrillation   is associated  with an  increase  in 
the  risk  of stroke by  a factor  of 5-7 times  that found  in persons with  sinus  
rhythm58. In persons who  have  heart  disease  not  complicated  by atrial  
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fibrillation,  the risk  of  stroke  is approximately  6%  per year. The presence  
of  arrhythmia   increases  this   risk to  approximately  15%  per year.  
 Atrial  fibrillation is   more common in persons who  have a history of 
hypertension,  diabetes  mellitus,  and smoking, even if  they do not have 
symptoms of heart disease. Afrial fibrillation  is also  more common  in 
persons with a  history of  congestive heart  failure34. Atrial fibrillation 
complicates several heart  deseases, and  a  majority of patients with atrial 
fibrillation  have an  underlying  cardiac abnormality. With  the decline in  the 
prevalence of  rheumatic heart disease secondary  to improved antibiotic 
treatment,  coronary  artery disease and  hypertension are the most  common  
heart disease associated with  atrial fibrillation.   
ACUTE MYOCARDIAL INFARCTION AND STROKE  
 Ischemic stroke is a leading non-cardiac complication of acute 
myocardial infarction. Some patients, especially diabetics, have relatively 
little pain at the time of myocardial infarction, and the acute cardiac event is 
not recognized. Thus, embolic stroke may be a  presenting symptom. The  risk  
of stroke following  myocardial infarction  probably has been  reduced by the  
widespread  administration of   thrombolytic,  antithrombotic,  and  
antiplatelet  aggregating  medications to  treat acute myocardial ischemia35,36. 
The risk  of  stroke  in persons  with  acute  myocardial infarction  appears to 
range from  1%  to 6%. The  occurrence  of a neurological  event is associated 
with  an increased risk  of death. In part, the   increased   mortality is 
secondary  to the brain injury. It  also  reflects  the  serious  ventricular  injury  
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that leads  to thromboembolism. A  strong time  relationship  for embolic  
complications  is  present. The first  days  and weeks  after  myocardial 
infarction are  the period  of highest  risk  for  embolism. Moore  et al37 
calculated that   the daily  risk for  stroke was  approximately  9/10,000 during  
the first  28 days  after myocardial  infarction. This  interaction should  not be  
surprising  because the first few  days after  the acute heart injury  are when  
cardiac  instability,  fresh  myocardial injury, and  changes in  coagulation  are 
most  likely. By 6  months  after  the cardiac  event,  the likelihood  of a 
complicating   stroke is  relatively  low.  This   time  interval  is important  
when  making  recommendations    about  anticoagulant  treatment  to prevent  
cardioembolic stroke  after  myocardial infarction.  
 The risk of  stroke after myocardial infarction  is increased  with an  
anterior  myocardial  infarction, a  history of  previous  myocardial infarction,  
hypertension,  atrial fibrillation,  or age  greater than 70. The risk in persons  
with non-anterior  myocardial infarction is  less than 1%  whereas  anterior  
injuries are associated  with a risk of  approximately  2% -6%. 
Echocardiographic  detection  of an intraventricular  or mural thrombus  is  
associated  with a markedly  increased risk  of  embolization. The thrombus 
usually  is adjacent to a hypokinetic or akinetic segment of the  left ventricle. 
Martin and Bogousslavesky38  noted that all  patients with stroke after  
myocardial infarction had  evidence of an  akinetic segment. Left ventricular 
thrombi  are rare in patients  with inferior  myocardial infarctions,  whereas 
up to  40%  of patients with anterior  infarctions have clots detected by  
imaging  tests. Embolism also  is more  likely   in  persons who  have  atrial 
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fibrillation,  congestive heart  failure,  or poor  left ventricular  function  
complicating  the myocardial  injury.  
 Anticoagulation  is  a key  component  of  the regimen  to prevent  
cardioembolic  stroke after  myocardial infarction39. Turpie et al reported that  
heparin  therapy lowered  the frequency  of mural thrombi from 32%  to 11%  
in a  group  of high-risk  patients,  reducing   the risk   by a ratio  of  0.46-0.60  
(0.30-0.90) 40. Most  patients are treated  with  anticoagulants,  antiplatelet  
aggregating  agents, and  thrombolytic  agents during  the first  hours after  
myocardial  infarction. Both anticoagulants  and  thrombolytic  agents  appear 
to prevent formation  of a mural thrombosis,  but  evidence  that antiplatelet 
aggregating agents  are effective  is  lacking. The  key to stroke prevention is  
to  identify the  highest risk patients and  continue  anticoagulation  for  at  
least 6 months. The  desired level  of anticoagulation is  an  INR of  2-3.  
STROKE IN  PATIENTS WITH  IMPAIRED LEFT  VENTRICULAR 
FUNCTION  
 The  relative risk  of stroke in patients  associated with   congestive 
heart failure  is about  4.1  among  those 50-59 yrs  of age1,2. The risk of   
stroke  associated  with cardiac failure  is  slightly  higher among  men than  
women,  but  impaired left ventricular  function  may be  a more  powerful 
risk  factor  for stroke  in women,  reflecting   the sex  related difference in the  
nature  of  underlying  cardio  vascular disease41.  
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EF  AND  HEART FAILURE  
 EF is the  proportion  of left  ventricular  volume   emptied  during  
systole. It  is  a reliable measure of  left  ventricular  systolic  dysfunction that 
can be  assessed   non invasively  by echocardiography  the normal  value  is  
50% to 70%  when left  ventricular  systolic function  is  impaired, EF 
declines  unless  there is  a corresponding  reduction  in workload,  as  ocurs 
in states of  peripheral vasodilatation or  valvular regurgitation. Consequences  
of low EF  include  elevated left   vertricular  filling  pressure  and a  fall  in 
stroke  volume   that reduces  the systemic  blood  flow. Peripheral  
vasoconstriction often  develops  to  a  degree  beyond  that required  to 
compensate  for the  fall  in cardiac  output  and maintain blood   pressure.  
Further more,  the reduced stroke  volume  creates a condition of relative 
stasis   with in  the left  ventricle  that may activate coagulation processes  and 
increase the risk of  thromboembolic  events. There is  a  significant risk  of   
thromboembolic  events for  every  10%  decrease   in EF   among   
population. The recurrent  stroke rate is much higher  than the rate of first-
ever  stroke in  patients with  cardiac failure.  
Roughly half  of patients with  symptomatic heart  failure in  the 
community  have reduced systolic function,  and half  have preserved 
function. The epidemiology  of  symptomatic heart failure  with reduced 
systolic function  differs from  that of  heart failure  with preserved systolic  
function; patients with  preserved  function are,  on average, older, higher 
proportions  are women or  have  comorbidity, and  they have  better  age-
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adjusted survival. The causes of  heart failure  in patients with  preserved 
systolic  function also  differ from  those with  reduced systolic  function.  
About  half  of cases of  left-ventricular systolic  dysfunction  are  
asymptomatic, which  raises questions   about   screening for  symptomless 
cases. The  syndrome of  heart failure  arises as  a  consequence  of  an 
abnormality  in cardiac  structure,  function,  rhythm,  or  conduction. In more 
developed countries,  ventricular  dysfunction is the  commonest  underlying  
problem. It  results  mainly from  myocardial infarction  (systolic 
dysfunction),  hypertension  (diastolic and systolic dysfunction),  or  in many  
cases both. Other  common  causes include "idiopathic"  dilated 
cardiomyopathy,  some  cases   of  which   could have  a genetic  basis, and   
alcoholic  cardiomyopathy.  
VENTRICULAR  REMODELING IN HEART FAILURE 
 Increased level  of  circulating  neurohormones are only  part of the 
response  seen  after  an initial insult to the myocardium. Left  ventricular  
remodeling is  the  process by which   mechanical, neurohormonal,  and 
possibly genetic  factors alter ventricular   size,  shape,  and  function. 
Remodeling  occurs  in several  clinical conditions,  myocardial infarction, 
cardiomyopathy, hypertension,  and  valvular heart  disease; its  hallmarks  
include  hypertrophy,  loss of  myocytes,  and  increased  interstitial  
fibrosis42.  
 For  example,  after a  myocardial infarction,  the acute  loss of  
myocardial cells  results  in  abnormal loading  conditions  that involve  not 
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only  the border zone   of the infarction, but  also  remote  myocardium. These  
abnormal loading conditions  induce  dilatation and  change   the shape  of the 
ventricle,  rendering it  more spherical,  as well  as causing  hypertrophy. 
Remodeling continues for  months after  the initial insult, and the   eventual 
change  in the shape43  of the ventricle  becomes  deleterious  to the  overall 
function of the   heart  as a pump.  
 Several trials  involving patients who  were  studied  after a myocardial 
infarction or  who had  dilated cardiomyopathy  found  a benefit from  ACE 
inhibitors,  beta-adrenergic  antagonists,  or cardiac resynchronization. Such  
beneficial  effects  were associated with  so-called reverse remodeling,  in 
which the  therapy  promoted  a return to  a more normal  ventricular  size and 
shape. The reverse -remodeling  process is  a mechanism through which  a 
variety of  treatments  palliate the heart - failure  syndrome.  
 The  myocardial conduction system is  vulnerable  to the  same  
pathophysiological  processes that occur in the  myocytes and interstitium, 
with  altered conduction properties observed in  response  to ischemia,  
inflammation,  fibrosis, and  aging.  Supraventricular arrhythmias, particularly 
atrial fibrillation,  are  often  the precipitating  events that herald the  onset of  
either systolic  or diastolic heart failure. Elevated ventricular end-diastolic 
pressure in a  patient with hypertension  or abnormal  myocardial function 
leads  to atrial  stretch,  which  in tun incites electrical  instability. 
Recognition  of the  presence of  atrial  fibrillation  in a  patient  is critical,  
since several  studies  have now demonstrated  the effectiveness of oral  
anticoagulant therapy  for the  prevention of  stroke44.  
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 Abnormal myocardial conduction can also  lead  to delays  in  
ventricular  conduction and  bundle-branch  block. Left  bundle- branch block  
is  a significant   predictor  of  sudden death and  a common  finding  in 
patients  with myocardial  failure. Its  presence also  affects  the mechanical 
events of the  cardiac cycle by causing   abnormal  ventricular  activation and   
contraction, ventricular dyssynchrony,  delayed opening  and closure  of the 
mitral and  aortic valves, and  abnormal  diastolic  function. Hemodynamic  
sequelae  include   a reduced  ejection fraction, decreased cardiac output and  
arterial pressure,  paradoxical  septal motion,  increased left  ventricular   
volume, and   mitral regurgitation45. Ventricular   arrhythmias are thought to  
be  secondary  to a dispersion  of  normal  conduction  through   
nonhomogeneous  myocardial tissue,  which  promotes  repetitive ventricular 
arrhythmias.  
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AIM OF THE STUDY 
 To study and evaluate left ventricular function in patients with 
ischaemic  stroke. 
 To analyse  whether LV dysfunction  could be a surrogate  marker for 
in hospital mortality  in patients developing  ischaemic  stroke. 
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MATERIALS AND METHODS 
STUDY DESIGN 
 Randomised  prospective  observational study. 
SETTING  
 Medical  wards of Government General Hospital, Chennai. 
 Study group   :  142  patients diagnosed as ischaemic stroke. 
 Period  of study  : April 2005 to September 2006. 
 LV  function was assessed by trans thoracic 2 - dimensional echo 
cardiography  in patients admitted with ischaemic  stroke under various 
medical units of our government general hospital  
EXCLUSION CRITERIA  
¾ Patients  under the age of  39 yrs  were excluded from the study 
group. 
¾ Patients with haemorrhagic stroke were excluded from the study 
group. 
¾ Patients with valvular heart disease were excluded from the 
study group. 
 All the study group patients underwent transthoracic 
echocardiopgraphy  as   a part of the study. 
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 All  patients had  a thorough  clinical , neurlogical  examination with 
careful evaluation   of history. Importance was given to symptoms and signs 
of cardiac disease in addition to neurological findings.  
 Routine laboratory tests included urine analysis, complete blood 
counts, serum electrolytes, blood glucose and serum cholesterol  
determination. Arterial hypertension was defined as presence of a positive 
history of antihypertensive treatment or blood pressure values >140 /90 mmhg 
on admission. Hypercholesterolemia  was defined as a total serum cholesterol 
>240mg /dl. or presence of appropriate  drug treatment earlier.  Diabetes 
mellitus was defined based on abnormal  fasting glucose >125mg /dl, positive   
history or presence of oral hypoglycemic agents intake or insulin treatment. 
Coronary artery disease included history of myocardial infarction or typical 
angina or the patients reporting of a positive diagnostic test (stress test, 
Coronary angiography) or drug treatment, 12 lead  ECG and CXR were   
taken for all the  patients . The neurological work up included  head CT  and 
the patients showing haemorrhage on the CT were excluded from the study 
group46. 
ECHOCARDIOGRAPHIC EVALUATION  
Transthoracic two dimensional echocardiography was performed  in all  
study patients. 
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LVEF was measured  by    the following formula      
LVEDV
LVESVLVEDV −    
LVEDV    =  LV end diastolic  volume 
LVESV    =  LV end systolic  volume 
LVEF was then categorised  as 
 Normal    = >50% 
Mildly decreased   =  41-50% 
Moderately decreased  =  31-40% 
Severely decreased   =  30% or less 
LV diastolic dysfunction was graded as47,48  
¾ Normal 
¾ Grade  I (delayed  relaxation) 
¾ Grade II  (  Pseudo normal filling) 
¾ Grade III ( restrictive filling ) based on mitral flow velocities 
and filling times. 
LVH was defined as49  
 Increase in interventricular septal thickness and posterior wall 
thickness beyond 1.1cm during diastole as excess by M-mode LV 
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measurements in parasternal long axis and apical  views in left lateral 
position.   
LV mass was derived using the formula described by Devereux and 
associates50
LV mass (grams)= 0.80x1.04 [(VSTd+LVIDd+ PWTd)3-(LVIDd)3]+0.6 
• VSTd is ventricular septal thickness at end diastole 
• LVIDd is LV internal dimension at end diastole 
• PWTd is LV posterior wall thickness at end diastole. 
LV mass was corrected for height 2.7 (LVMI), and expressed in units of 
grams/meter (g/m 2.7). The presence of left ventricular hypertrophy was 
defined for LVMI >51g/m2.7  in either gender. 
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RESULTS 
AGE  
142 Patients of the study group were divided into various  sub groups. 
Ischaemic stroke was most commonly observed between 51-60 years of age 
followed by patients aged 61-70 years .The mean  age of the patients was `58 
years. 
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SEX 
 Most of  the patients   were men ( 66 %) as against women (34%) 
SEX DISTRIBUTION
66%
34%
 Men Women
 
 
 
 
 
 
 
RISK FACTOR PROFILE 
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Smoking 
  Smoking was one of the most common risk factor observed in 73 
patients. 
 All  of these patients were men. Out of 94 men, 73 patients  were 
chronic  smokers (51%). The mean age of the smokers was 54 years. 
Associated history of  chronic  alcohol intake was seen in 33 male patients. 
Associated hypertension was seen in 11 patients which  had statistical 
significance  (P- value .00). Coexisting  diabetes mellitus was observed in 8 
patients. This   correlation  had a statistical significance  (P- value .01) Prior 
history of coronary artery disease  was obtained in 6 patients.  This  was not 
statistically significant. Hypercholesterolemia was noticed in 42 patients. Past 
history of stroke was  present in 25 patients.  History of shortness  of breath of 
varying degree  suggestive of left  heart failure was observed in 20 patients.  
History of angina  and palpitation was observed in 13 patients.  There 
is no statistical significance associated  with the  heart  failure symptoms 
among the smokers. 33 of the 73 patients had ECG changes of varying degree 
out of which 12 patients had ECG changes suggestive of left ventricular 
hypertrophy. 7 patients had ECG Changes of previous of myocardial 
infarction. 13  patients showed changes in the chest  x- ray.  8 patients had 
cardiomegaly in the chest x- ray . Echocardiographically  LVH  was  evident 
in 34 patients. E diastolic dysfunction was present   in 5 patients. Clinical 
picture of stroke w as severe in smokers associated  with altered mentation, 
dense hemiplegia and massive  infarct on the C.T . This association  had 
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statistical significance  (P= value  .00). In hospital mortality was  observed  in 
3 patients . 
Alcohol 
 Alcohol intake  was observed in 33 of the 94 men (23%). All  of  them    
were men. They had associated history of  chronic  smoking. 21 patients had 
associated hypercholesterolemia. 4 patients  had diabetes mellitus and 4 
patients had coronary artery disease. Shortness  of  breath  on exertion was  
observed in  7 patients.  History  of angina, palpitation was present  in 6 
patients. Chest skiagram  showed cardiomegaly  in  1 patient. Echographically 
L.V.H was evident in  13 patients. L.V. systolic dysfunction was present in 6 
patients. Diastolic dysfunction was present in 3 patients. One patient had in 
hospital  mortality. 
Hypercholesterolemia  
 78 of the 142 patients had  hypercholesterolemia (54%). Out of which  
58 were men and 20 were women. It was  the most common risk factor 
observed among the study group patients. It was  most commonly observed in 
the age group between 51-60 years followed by 61-70 years. The mean range 
of blood cholesterol was between  240-260 mgms%. 14 patients had 
associated diabetes mellitus. 25 patients had associated hypertension.  
Hypertension had statistically significant association with 
hypercholesterolemia. ( P= value .04).  5 patients  had past history of coronary 
artery  disease . 
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Previous history of stroke was  present in 24 patients. Echocardiographically 
L.V.H was seen in  29 patients. 14 patients had left ventricular systolic 
dysfunction. 8 patients  had left ventricular diastolic dysfunction.   C.T  scan 
showed massive infarct in 35 patients. This had statistical significance  
(P- value- .02). 7 patients had  mortality in the hospital.  
Hypertension 
 Hypertension was observed in 56 of the 142 patients studied ( 39.4% ). 
It was most commonly observed in the age group between 50 – 70 years when 
compared to those below 50 years and more than 70 years of  age  group. It 
was more frequent in women compared to men in the ratio of 36:20  
17 patients had   history of  angina  and palpitation. History of 
shortness of breath was observed in  hypertensive patients which had no 
statistical significance.   
  Co existing   diabetes mellitus was seen in 6 patients. Co existing 
hypercholesterolemia was observed in 25 patients. 5 patients had associated 
coronary artery disease (P- value  .02).37 patients had E.C.G changes . 
Echo cardiographically LVH was evident in 29 patients.  40  out of 56 
patients had normal LV systolic function 16 patients had LV systolic 
dysfunction. 5 patients had LV diastolic   dysfunction . 5 patients had 
mortality  during the hospital stay.  
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Diabetes Mellitus  
 26 of the 142 patients had  diabetes mellitus (18%). It was observed as 
a  risk factor equally in both sexes (P= value .05).  Previous history of 
coronary artery disease was  present in 12 patients.  Coexisting  C.A.D was 
more commonly seen in men  compared to women . Past history of stroke was 
present in 8  patients. History  suggestive of angina  , palpitation  and 
shortness of breath  was observed among the diabetic spatients  which had no 
statistical significance. ECG  changes of previous myocardial infarction  was 
seen in  6 patients. This was associated with statistical significance (P= value 
.03). Chest X-ray showed cardiomegaly  in 8 patients  with statistical     
significance (P= value .02). 14 patients had left ventricular systolic 
dysfunction  echocardiographically. Two patients had left ventricular diastolic 
dysfunction. 1 patients had LVH. Two patients had  in hospital stay mortality 
with statistical  significance  (p value .00).  
Coronary Artery Disease 
 History of coronary artery disease was present in  12 patients (8.4%) 
C.A.D w as more frequent  in men when compared to women in the ratio  of 
8:4. Most common age group with C.A.D was between 51-60 years. History 
of  breathlessness on exertion of  NYHA class III was more frequently   
observed in   C.A.D patients. This association had statistical significance  
(P= value .00). Past history of stroke was obtained  in 3 patients. Associated 
diabetes mellitus  was present in 12 patients.  Hypertension was  seen  in 5 
patients. Elevated  cholesterol levels were found in 5 patients. E.C.G changes 
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of previous M.I  was observed in  11 patients ( P= value 0.00). Cardiomegaly  
was seen in the chest x- ray among 5 patients. This association was 
statistically significant  (P value .01).  Echocardiographically LVSD was 
evident in   all 12 patients with statistical significance  (P= value 0.00).  
7  C.A.D. patients had dense hemiplegia.  One patient expired in the hospital. 
SYMPTOMS OF C.A.D AND CARDIAC DYSFUNCTION  
  History suggestive of angina was observed in  29 patients (20%).  H/O 
of palpitation was observed in 29 patients (20%)  in the absence of valvular 
heart disease. Exertional breathlessness  of varying degree was present in 49 
patients. 4 out of 49 patients had shortness  of  breath at rest.  
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 Symptoms of angina and  palpitation were more  frequently  observed 
in 20 patients with  hypercholesterolemia (P value .03).  14 out of  49 patients 
had  chest  x-ray  changes of  cardiomegaly.  This was associated with  
shortness of breath  N.Y.H.A class III and IV . This association had   
statistical significance  (P value 0.00). E.C.G changes of previous M.I was 
present in 9 out of 49 patients. All of them had  breathlessness  at rest  
(P value 0.00). This association was statistically  significant.  There was no 
statistically significant association  between symptoms of  left heart failure  
with diabetes mellitus and hypertension. Left ventricular  systolic dysfunction 
was evident echocardiographically in  9 patients with severe heart failure 
symptoms.  This association was statistically significant  (P= value 0.00).  
Past H/O stroke was observed in 6 patients. 7 patients had altered  mentation  
(P =  value 0.00).  
11 patients had massive infarct on C.T. There was no statistically 
significant correlation between  symptoms of   left heart   failure and mortality 
in the present study. 
PAST HISTORY OF STROKE 
 Past history  of stroke  was present in 41 out of 142 patients.   Out of 
which most of them were between  51 – 60 years of age. Men had more 
incidence of past H/O stroke men compared to women in ratio of 3:1.  Out of 
41 patients 16 had  dense hemiplegia, 14 had altered mentation  C.T changes 
of massive infarct was evident  23 patients. The  severity of  the stroke and 
clinical picture  had significant  statistical  correlation  with a  P value of .00 . 
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ELECTROCARDIOGRAPHIC CHANGES 
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Electrocardiographic changes  were observed  in 76 out of 142  
patients ( 53% ). More men had E.C.G changes  when compared to women in 
the ratio of 43:33. E.C.G changes of LVH was more frequently observed in 14 
hypertensive patients followed by 10  smokers. 
 There was no significant  association between H/O angina, palpitation 
with E.C.G changes. E.C.G. changes  of previous M.I was observed in 11 out 
of 76 patients. All of them had  shortness of breath on mild exertion and at 
rest. This association was statistically significant (P =value .00). 7 out of 11  
patients with  E.C.G   changes  of previous M.I had cardiomegaly on chest x- 
ray.  This correlation had statistical significance( P= value .00). E.C.G 
changes of  previous  M.I  was more frequently seen among the 11 out of 12 
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patients with past history of C.A.D followed by 6 diabetic patients. 19 out of 
76 patients had  dense hemiplegia. 11 patients with  previous M.I changes  
had massive  infarct on C.T . 4 out of 17  patients with B.B.B changes  had 
diastolic dysfunction  in the echocardiography.  Another 4 patient with B.B.B 
changes had L.V  systolic dysfunction 27 patients of   varying E.C.G changes 
had L.V  systolic   dysfunction. 19 out of 24 patients with E.C.G changes of 
LVH echocardiograthically which was statistically significant (P =value .00). 
9 out of 11 patients with  ECG  changes of previous  MI had dense  
hemiplegia. This was also statistically significant  (P = vlaue .00). 12  patients  
with changes of previous M.I had  massive infarct on C.T  (P value .00)  
ECG changes of arrythmias was observed in 13 patients with 
hypercholesterolemia  and 10 patients  with  hypertension.  There was no 
statistical significance in the above association.   
CHEST  X-RAY CHANGES 
28 patients had changes on chest  skiagram. 5 patients had  chest x- ray 
changes of pulmonary venous congestion. 23 patients had cardiomegaly on 
chest x – ray. Men  and women showed chest x-ray changes  in  proportion of 
16:12. 14  out of 23 patients with cardiomegaly on chest x- ray had  N.Y.H.A 
class III and IV symptoms (P= value .00). All of the above patients  had left 
ventricular systolic dysfunction  which had no statistical significance.  
3 patients had L.V diastolic dysfunction.  
 31
ECHOCARDIOGRAPHIC CHANGES  
 112 out of  142 patients had normal left ventricular systolic  function  
echocardiographically.  
¾ 13 patients had mild left ventricular systolic dysfunction 
(9.15%). 
¾ 11 patients had moderate left ventricular systolic dysfunction  
( 7.75%). 
LVSD CORRELATION WITH AGE 
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More number of patients were in the age group beteween 51-60 years 
followed by 61-70 years.  
More men had left ventricular  systolic dysfunction when compared to 
women in the ratio of 18:12. 
16 hypertensives had left ventricular systolic dysfunction  
(P value = 0.12).  14 diabetic patients left ventricular systolic dysfunction 
which was statistically significant (P value .00). All the 12 C.A.D  patients 
had moderate to severe left ventricular systolic dysfunction(P value = 0.00).  
14 patients with  N.Y.H.A class III symptoms  had L.V.S.D (P value = .00). 
LVSD CORRELATION WITH RISK FACTORS
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LEFT VENTRICULAR HYPERTROPHY 
Left ventricular hypertrophy was observed  in 65 patients.   
echocardiographically .Most of them were in  the age group between  60-70 
years followed by 50-60 years of age. More number of men had L.V.H  when 
compared to women in the ratio  of 41: 24 . L.V.H. was observed   commonly  
in 39 smokers followed by 29 hypertensives.  It was also evident in  
13 alcoholics.   15 patients with L.V.H had history of angina and palpitation.  
NYHA class I symptoms  where frequently observed in patients with L.V.H   
(P value = 0.09). 16 patients with LVH  had  dense hemiplegia  
(P value = 0.03). Massive infarct on C.T was evident in 18 patients  
(P value = 0.04). 6 patients had associated  diastolic dysfunction  
echocardiographically. However this association was not statistically  
significant. 19 patients  with E.C.G. changes of LVH had  LVH 
echocardiographically. 11 patients with cardiomegaly  on chest x-ray had 
L.V.H echocardiographically 9 patients with L.V.H had  left ventricular 
systolic dysfunction echocardiographically . This association was statistically 
significant (P value= 0.02). 3 patients with L.V.H  had in hospital mortality.  
DIASTOLIC DYSFUNCTION 
 12 out of 142 patients had diastolic dysfunction  echocardiographically  
5 patients were in the age  group between 51-60 years followed by 4 patients 
in the  age group less than 50 years. 
 The number of men with diastolic dysfunction was more when 
compared to women in the ratio of 7:5.  
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ECHO FINDINGS CORRELATION WITH SEVERITY 
AND EXTENT OF STROKE
0
10
20
30
40
50
60
70
L.V.H Normal
LVSF
Mild LVSD Moderate
LVSD
Severe
LVSD
Grade I DDF Grade II
DDF
Echo Findings
Past H/o Stroke Recovering Hemiparesis Dense Hemiplegia
Altered Sensorium C.T. Normal Lacuner Infarct
Massive Infarct Mortality
 
 There is no statistically significant association between diastolic 
dysfunction and   history of angina, palpitation and symptoms  of left heart 
failure  5 hypertensive patients had diastolic dysfunction. 2 diabetic patients  
had diastolic dysfunction. One patient with history of C.A.D had diastolic 
dysfunction. There was no statistically significant association between D.D.F 
and chest X- ray, E.C.G changes. 
 An attempt was made  to correlate  the clinical parameters of stroke – 
including  severity of stroke,  altered mentation,   extent of stroke  on C.T  and  
mortality with  L.V function. L.V diastolic dysfunction  had statistically 
significant association  with mortality  when compared to L.V systolic 
dysfunction.  
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IN HOSPITAL  MORTALITY   
  9 out of 142 patients had in hospital mortality.  The average period of 
hospital stay was 12 days among this group. 3 were aged between 51 to 60 
years  and above 70 years. Death was observed  more commonly in men (ratio  
of men: women being 5:4 ).  Among those who expired, hypercholesterolemia 
was seen in  7 patients.  Hypertension was observed in 5 patients. 2 patients 
had  diabetes mellitus. One patient had coronary  artery disease. 5 patients had 
symptoms of cardiac dysfunction on admission.  This association between  the 
symptoms of left heart failure and mortality had statistical significance ( P 
value .00). cardiomegaly on chest skiagram was observed in 4 out of 9 
patients.  This association was statistically significant (P value .00). 
 Echocardiographic evidence of left ventricular dysfunction was 
observed in 4 patients. Out  of which  2 patients had L.V. systolic dysfunction 
and 2 patients had L.V diastolic dysfunction. The  association between  
L.V. diastolic dysfunction and mortality  was statistically significant   
(P value 0.00). 
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DISCUSSION 
The  number of patients enrolled  in the study was 142. V function 
studies  in  association with ischaemic stroke have been done by Allison  G. 
Hays, M.D, Department of Medicine, New York (`1994-1997) in a subset of  
patients from the  Northern Manhattan  study 2006(NOMAS) 46. 
In a study  done by them, 270 patients of ischaemic stroke were  
evaluated for LV function.  Framingham study and  VH ef trial51 analysed the 
various risk factors in association  with LV  dysfunction in  ischaemic stroke 
patients. 
  E.C.G changes  in stroke patients were analysed by DS. Goldstein53 
during 1979. In SOLVD55 study, heart failure  in stroke patients was 
evaluated. 
AGE INCIDENCE 
 Among the patients studied 33%  were between 51-60 years followed 
by 29% between 61-70 years. The average age of patients studied was 
58years. The lesser incidence in people below 50 years of age could be 
because in our study  we excluded patients with valvular heart disease and the 
causes of young stroke. The number of patients of over 70 years was also less   
is possibly   because  less no of people live beyond this age.  The age 
incidence in the current  study was similar  to the northern manhattan study. 
In the  NOMA   study  also the age of patients  more than 70  and younger 
than 50 years was less.   
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SEX INCIDENCE 
 66%  of patients in the present study were men as  against 34% who 
were women. This is probably  because smoking and intake of alcohol was 
observed in a majority of men in our group. This contrasts with the manhattan 
study  figures  (NOMA study) where 56% were women against 44% men. 
 The higher incidence of stroke in women  of NOMA study could be 
due to the associated  habits of smoking and alcohol intake  in western  
women. 
RISK FACTOR  PROFILE  
Smoking 
 51% of patients in current study were chronic  smokers where as in 
NOMA study 23% were  smokers. This difference could be due to the  higher  
incidence of  smoking in Indian men when compared to people of        
Western country where     the habit of  smoking was  comparatively less than 
alcohol    intake. The present study   showed statistically significant 
association  between smoking, hypertension and diabetes. The association 
between smoking and clinical severity and morbidity of  the stroke was also  
statistically significant in the present study . 
Alcohol  
 The incidence of alcohol intake was more in the NOMA study when 
compared to the present study. It was 40% in the  NOMA study as compared 
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to the 23%  of  present study.  This difference could  be attributed to the  
higher incidence of alcohol intake in Western countries  when compared to 
our country. 
Hypercholesterolemia 
 The incidence of hypercholesterolemia  was more in the present study 
(54%) where as it was less in the NOMA study  (38%). The above  difference 
could be due to the changes in the life style pattern of the people of our 
country with associated alcohol intake and smoking and also due to the 
increase   in associated co morbid conditions like atherosclerosis, diabetes  
hypertension and C.A.D. 
Hypertension  
 The incidence of hypertension was  39% in  present study which was 
less when compared to NOMA study (i-e 78%). This  could be  due to the 
difference in the  incidence of    comorbid conditions like   diabetes, C.A.D, 
dyslipidemia.  The association of  hypertension and C.A.D was statistically 
significant in the  present study. The ECG changes of LVH and hypertension 
was statistically significant in the present study. 
DIABETES MELLITUS 
 The incidence of diabetes in  the present study was 18.3% as compared 
to the NOMA study of 43%.  The above difference due to the sedentary  life 
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style  of the western people  and also due to the higher incidence of obesity 
among the  people of western countries . There was a statistically significant   
correlation between diabetes and LVSD. In hospital stay  mortality was 
statistically significant  among diabetic patients. 
CORONARY ARTERY DISEASE 
 The incidence of C.A.D. was 8.4% in the  present study as compared to 
the NOMA study of 31%  the above difference could be due to the higher 
incidence of CAD in  Western countries. Also this could be attributed  to  
increase in associated comorbid conditions like diabetes, hypertension and 
dyslipidemia. The severity  of the  symptoms of left  heart failure had 
statistically significant correlation with CAD in  present study. ECG changes 
of M.I and  CXR changes of cardiomegaly had significant correlation  with 
CAD in present study. LVSD was more  commonly  observed in  present 
study with statistical significance    
SYMPTOMS OF CAD AND CARDIAC DYSFUNCTION 
 Since we were assessing the echocardiographic evidence of  LV 
dysfunction,  we evaluated the cardiac dysfunction in detail.  
The symptoms of cardiac dysfunction was observed in the study group 
patients on admission. 20% had H/O angina   and  49 patients had shortness of 
breath of varying degree.   4 patients  had  shortness of breath at rest. There 
was significant correlation   between shortness of  breath  of severity and 
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E.C.G changes of previous  M.I.  Shortness of breath  of at rest  had a 
significant correlation with LVSD in present study. Clinical picture   of  
stroke with altered mentation and severity of the stroke had statistically 
significant correlation with cardiac  symptoms. 
PAST HISTORY OF STROKE 
 Past history of stroke was obtained in all stroke patients in the present 
study. This was elicited  to evaluate the significance of recurrent stroke in 
study group patients. H/O of recurrent of stroke was observed in more men 
when compared to women in the present study. This could be attributed to the 
difference in the number of men and women of study group. Associated 
smoking  and alcohol habits were observed in men  which was not  observed 
in  women .  The severity of the stroke  and clinical picture had significant 
statistical correlation with past H/O of stroke (P value = .00). 
 The recurrent  stroke rate is much higher than the rate of first-ever 
stroke in patients with cardiac failure. Sacco et al54.  found a 45% 5- year 
recurrent stroke rate in patients with cardiac failure. 
ELECTROCARDIOGRAPHIC CHANGES 
 E.C.G changes in the stroke patients were compared with a study of 
E.C.G changes  in stroke patients  by DS Goldstein 197953 . 
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DS Goldstein study 1979 
(Number of patients = 150) 
Present Study 
((Number of patients = 142) 
Abnormal E.C.G  (Total)         92%   53% 
E.C.G. changes of       
arrhythmias                               28% 
(including tachycardia ) 
 
14% 
E.C.G. changes of L.V.H       26% 16.9% 
E.C.G changes of  
-previous M.I                          20% 
11% 
E.C.G changes of  
- B.B.B                                    20% 
12% 
 
 The present study group patients had less frequency of E.C.G changes 
when compared to DS Goldstein study. However, the E.C.G changes of 
L.V.H   and   E.C.G changes of arrhythmias followed by E.C.G changes of 
previous M.I were commonly observed in both the studies . The above E.C.G. 
changes could be attributed to the underlying hypertensive, atherosclerotic 
cardiovascular  disease,  sympathetic hyperactivity, and possibly myocardial 
necrosis. 
 The current study showed that the E.C.G changes of previous M.I  had 
a statistically significant  correlation with severe heart failure symptoms of 
NYHA class III and IV (P value =.00). The above patients also had a 
statistically significant association with chest x – ray changes of 
cardiomegaly(p value =.00). 
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CHEST X-RAY CHANGES 
 Chest x- ray changes of cardiomegaly was observed in 23 patients. Out 
of the 23 patients 14 had NYHA class III and IV  symptoms  with statistical 
significance  (P value = .00). The above patients also had left ventricular 
systolic dysfunction echocardiographically . However, this association  was 
not significant statistically. 3 patients had diastolic dysfunction  
echocardiographically. This association had no statistical significance. The  
patients with  chest x- ray changes of cardiomegaly  had  significant  dense 
hemiplegia and massive infarct  on C.T . This association between CXR 
changes  of cardiomegaly  with clinical severity and extent of stroke  had 
statistical significance (P value .00). 
 16% of the patients had cardomegaly on CXR. Studies in  ischaemic 
stroke patients on CXR findings are  not much. However, in U.K  T.I.A52  
study showed an association of 8%  cardmegaly  in T.I.A patients.  The above 
difference could be attributed to the more incidence of  cardiomegaly in 
completed stroke patients. 
ECHOCARDIOGRAPHIC CHANGES 
 30 patients had left ventricular systolic dysfunction  in the present 
study (21.13%) .  The L.V.S.D changes of present study group was compared 
with L.V.S.D changes of NOMA study group  as follows: 
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NOMA study (1994-1997) 
number of patients – 270 
Present study 
number  of patients -142 
LVSD 
Mild                     10.7% 
 
9.1% 
Moderate /severe 13.3% 11.98% 
LVSD  
any level               24.1% 
21.13% 
 
 LVSD of any degree was more frequent in stroke patients of the 
present study group. The incidence of LVSD was comparatively similar in 
both  study groups. However, in the present study more men had LVSD than 
women in the ratio of 18:12.  This association  of higher incidence of LVSD 
in men was  not  statistically significant (P value = .13). In NOMA  study, 
incidence in men and women   was not much  different ( P value = .65). 
  LVSD  was more common in the age group between 50-60 years 
followed by 60-70 years in the present study ( P value 0.78). LVSD of  any 
degree was  significantly associated with ischaemic  stroke among all age 
groups in NOMA study ( P value 0.57). 
 16 hypertensives had L.V.S.D in the present study (P value= 0.12).  14 
diabetic patients had LVSD  with statistical significance ( P value= 0.00) All 
the patients  with E.C.G changes of  previous M.I  had LVSD of moderate to 
severe degree  with statistical significance (Pvalue = 0.00). Clinical symptoms 
of severe heart failure (NYHA class III –IV ) had a statistically significant 
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correlation  with LVSD ( P value 0.00).The patients with dense hemiplegia, 
altered sensorium  associated with  massive infarct on C.T had  significant 
association with LVSD( P value = 0.00). LVSD had no statistically significant 
correlation with mortality in the present study. 
 In the survival and ventricular  Enlargement (SAVE) study56,  patients 
with an EF of 29% to 35% had a stroke rate of 0.8% per year; the rate in 
patients with EF of 28% or less was 1.7% per year. There was an 18% 
increment in the risk of stroke for every 5%  decline in EF. 
DIASTOLIC DYSFUNCTION 
 12 patients had diastolic dysfunction in the present study. Most of them 
were between 51-60 years followed by less than 50 years. The  number of 
men was more than women  in the ratio of 7:5.  
 Diastolic dysfunction was more frequent  in hypertensives than 
diabetics in the ratio of 5:2. One patient with C.A.D had  diastolic 
dysfunction. There is no statistically significant association between  history 
of angina, palpitation and symptoms of left  heart failure and diastolic 
dysfunction.  The association  between D.D.F and chest x- ray, E.C.G changes  
is also  statistically not significant. There is no significant association between 
diabetes,  C.A.D and  diastolic dysfunction in the present study.  However, 
association   between mortality and diastolic dysfunction was statistically 
significant (P value = 0.01). 
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 IN HOSPITAL MORTALITY  
 9 patients had in hospital mortality in the present study. Mortality was 
more in men than women in the ratio of 5:4.  7 out of 9 patients had 
hypercholesterolemia. 5 patients had hypertension. Two  patients had diabetes 
mellitus. One patient had coronary artery disease.   
NYHA class I symptoms was observed in two patients on admission  
(P value =0.00).  Cardiomagely  on chest x- ray was observed in four patients. 
This association was statistically significant (P value= 0.00). The clinical 
picture and extent of stroke was  also  severe  among the patients with 
diastolic dysfunction. Four patients had altered sensorium, 5 patients had 
massive infarct on C.T, one patient had dense hemiplegia ( P value =0.04) 
  
 46
CONCLUSIONS 
•  LVSD was  observed in 30 patients of the present study (21.13%).   
• Diastolic dysfunction was observed among 12 patients (3.4%). 
• Association of LVSD with clinical severity and extent of the stroke had of 
positive  correlation  statistically . 
• Association of LVSD with in hospital stay mortality was not significant. 
• Hypercholesterolemia was observed as the most  common risk factor 
among the ischaemic stroke patients. 
• Coexisting coronary  artery disease and diabetes mellitus  had positive 
correlation with left ventricular systolic dysfunction. 
• Smoking was one of the most common risk factor observed among the 
ischaemic stroke patients. 
•  Patients with symptomatic  heart failure of NYHA class III and IV had  a 
positive  correlation with left ventricular systolic dysfunction  and clinical 
morbidity  in ischaemic stroke. 
• ECG changes of previous MI had statistically significant correlation with 
left ventricular systolic dysfunction and clinical morbidity in ischaemic 
stroke 
• Chest x- ray changes of cardiomegaly was observed among 4 out of 9 
patients with in hospital stay mortality. 
• LVSD had no positive correlation  with mortality . 
• 6 out of 12 patients with diastolic dysfunction were asymptomatic.  
PROFORMA 
 
Name:    Age:   Sex: 
D.O.A:   D.O.D:  I.P.NO: Ward 
Complaints: 
¾ Headache 
¾ Vomiting 
¾ Seizures 
¾ Loss of consciousness 
¾ Aphasia 
¾ Sensory Disturbance 
¾ Weakness of limbs 
¾ Symptoms of  cardiac dysfunction 
¾ H/O angina 
¾ H/O palpitation 
Breathlessness on exertion 
Past History: 
¾ Diabetes 
¾ Hypertension 
¾ T.I.A 
¾ H/O Cerebrovascular accident 
¾ C.A.D 
Personal History 
¾ Alcohol Intake 
¾ Smoking 
Treatment History 
General Examination 
Pulse : 
B.P. : 
C.V.S : 
C.N.S : 
Higher Functions 
Cranial Nerves  
Motor 
Sensory 
Other Systems 
Investigations 
¾ R.F.T 
¾ C.H.G 
¾ Lipid Profile 
¾ 12 lead E.C.G 
¾ Chest X- ray  
¾ Echocardiography  
¾ C.T Brain 
 
Mortality 
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S.No. age sex smoke alcohol H.T D.M C.A.D ANGINA PALPIT 
NYHA-
1 
NYHA-
2 
NYHA 
3 
NYHA 
4 H.C ECG1 ECG2 ECG3 ECG4 ECG5 
1 65 M + +                   +   +       
2 70 M +                     +     +     
3 56 M + + +   +           +       +     
4 75 M     +                 +       +   
5 55 M + +                   + +         
6 40 M +           1 1             +     
7 56 M +                     +     +     
8 70 M     1                   1         
9 40 M +  + 1                 1 1         
10 56 M +  +                   1 1         
11 60 M +                        1         
12 40 M + +   1     1         1 1         
13 67 M +     +   + + +       +     +     
14 63 M +    +                 + +         
15 65 M +    +                   +         
16 50 M +  +   +     +         + +         
17 62 M +                       +         
18 67 M +  +     +         +   +       +   
19 40 M +  +     +         +           +   
20 55 M +  +                     +         
21 49 M +    +                 +   +       
22 64 M +                       +         
S.No. age sex smoke alcohol H.T D.M C.A.D ANGINA PALPIT 
NYHA-
1 
NYHA-
2 
NYHA 
3 
NYHA 
4 H.C ECG1 ECG2 ECG3 ECG4 ECG5 
23 80 M +  +       +           + +         
24 40 M +                       +         
25 45 M + +                   + +         
26 41 M +                       +         
27 60 M +                         +       
28 50 M     + + +       +     +       +   
29 52 M                       + +         
30 52 M             +         + +         
31 72 M                       + +         
32 42 M                       +     +     
33 80 F           +   +       +       +   
34 70 F     + +   +               +       
35 51 F                           +       
36 75 F       +               + +         
37 63 F     + +   +                 +     
38 48 F     +                       +     
39 80 F             +         + +         
40 68 F     +         +       +     +     
41 70 F     +         +       +   +       
42 56 F     +           +         +       
43 69 F     +           +     +   +       
44 45 F               +                 + 
S.No. age sex smoke alcohol H.T D.M C.A.D ANGINA PALPIT 
NYHA-
1 
NYHA-
2 
NYHA 
3 
NYHA 
4 H.C ECG1 ECG2 ECG3 ECG4 ECG5 
45 70 F     +         +         +         
46 80 F     +       +   +     +         + 
47 45 F     +     + + +       + +         
48 68 F     +     + +         + +         
49 80 F     +     + +   +               + 
50 65 F       +     +   +     + +         
51 55 F     +     +           + +         
52 50 F           + +           +         
53 63 F                 +     + +         
54 65 F           +     +     + +         
55 50 F     + +                   +       
56 65 F                           +       
57 43 F     +                   +         
58 50 F     + +                     +     
59 55 F     +                   +         
60 55 F       +                 +         
61 48 F     +                       +     
62 55 F     +             +   +         + 
63 75 F     +     +                 +     
64 70 F                 +       +         
65 55 F     +     +                 +     
66 43 F     +                   +         
S.No. age sex smoke alcohol H.T D.M C.A.D ANGINA PALPIT 
NYHA-
1 
NYHA-
2 
NYHA 
3 
NYHA 
4 H.C ECG1 ECG2 ECG3 ECG4 ECG5 
67 58 F     + + + + +     +   +       +   
68 70 F     + +   +         + +       +   
69 50 F     +                       +     
70 45 F     +                       +     
71 62 F     + +                     +     
72 54 F     +   +           +         +   
73 70 F     +                       +     
74 66 F     +       +                   + 
75 50 F     +   +   +                 +   
76 65 F     + +   + +         +   +       
77 70 F     + + +     +       +       +   
78 65 F     + +                         + 
79 39 F     +                 +         + 
80 57 F     +         +       +   +       
81 75 M     +         +         +         
82 75 M         +         +   +       +   
83 60 M             +         +   +     + 
84 60 M +         +           +   +       
85 90 M       +     +         +         + 
86 42 M +         +               +       
87 64 M     + +       +       +         + 
88 72 M + +             +       +         
S.No. age sex smoke alcohol H.T D.M C.A.D ANGINA PALPIT 
NYHA-
1 
NYHA-
2 
NYHA 
3 
NYHA 
4 H.C ECG1 ECG2 ECG3 ECG4 ECG5 
89 84 M     +     + +   +     +   +       
90 58 M     +         +       + +         
91 52 M +           + +       +     +     
92 72 M +                 +   + +         
93 48 M + +                   +   +       
94 55 M + +       + +         +         + 
95 52 M +         +   +       + +         
96 65 M +         + + +       + +         
97 40 M + +                   + +         
98 62 M +           +   +             +   
99 88 M + +       + +         + +         
100 45 M + +         +         + +         
101 54 M + +       +           + +         
102 48 M +         +           + +         
103 56 M +           +         + +         
104 75 M     + +       +       + +         
105 65 M +         + +   +     +         + 
106 50 M +                     +     +     
107 70 M +                 +   +   +       
108 63 M + +                     +         
109 74 M + +                     +         
110 52 M +   +                 +   +       
S.No. age sex smoke alcohol H.T D.M C.A.D ANGINA PALPIT 
NYHA-
1 
NYHA-
2 
NYHA 
3 
NYHA 
4 H.C ECG1 ECG2 ECG3 ECG4 ECG5 
111 62 M + +             +         +       
112 70 M                         +         
113 43 M                         +         
114 51 M +   +                       +     
115 60 M + +                   +         + 
116 82 M                       +         + 
117 50 M +                 +   +       +   
118 59 M                   +   +   +       
119 48 M + +                     +         
120 42 M +                               + 
121 45 M +                     +   +       
122 42 M   +                   +   +       
123 66 M +                     +     +     
124 69 M +   + +           +             + 
125 78 M +     + +                     +   
126 53 M + +                   + +         
127 80 M +                 +     +         
128 66 M +                       +         
129 60 M + +                     +         
130 40 M + +                   + +         
131 47 M +                     + +         
132 80 M +     +           +   +         + 
S.No. age sex smoke alcohol H.T D.M C.A.D ANGINA PALPIT 
NYHA-
1 
NYHA-
2 
NYHA 
3 
NYHA 
4 H.C ECG1 ECG2 ECG3 ECG4 ECG5 
133 60 M +                           +     
134 56 M + +                         +     
135 60 M + + + +                     +     
136 64 M + +     +           +         +   
137 55 M +   +                 + +         
138 60 M +     + +         +           +   
139 70 M +   +     + +           +         
140 75 M +         +           +           
141 62 M + +                   + +         
142 55 M     + +   + +     +     +         
 
Smoke - Smoking,  H.T - hypertension,  D.M - Diabetes Mellitus,  CAD    -   Coronary artery disease, 
NYHA - New York Heart Association,  H.C - Hyper cholesterolemia  ECG1 -   Normal   ECG 2  -  Arrhythmia  
ECG 3 -  LVH       ECG 4  - Previous MI       ECG 5 - BBB
 S.No. age sex CXR1 CXR2 L.V.H ECHO-
NSF 
MILD MOD Severe DDF1 DDF2 DDF3 
H/O 
Stroke 
Rec. 
HP 
Dense 
HP 
Alt. 
Sens 
CT 
- N 
Lac. 
Infr 
Mass 
Infr 
MORT 
1 65 M     + +               +     +       
2 70 M       +                 +   +       
3 56 M             +       +   +           
4 75 M     + +               +       +     
5 55 M       +               +     +       
6 40 M       +               +     +       
7 56 M     + +                 +     +     
8 70 M       +                 +       +   
9 40 M     + +             + +     +       
10 56 M       +               +     +       
11 60 M       +               +       +     
12 40 M       +               +     +       
13 67 M     + +               +     +       
14 63 M       +               +     +       
15 65 M       +                 +   +       
16 50 M       +             +       + +     
17 62 M       +               +             
18 67 M +         +             +       +   
19 40 M           +               +         
20 55 M     + +       +       +       +     
21 49 M     + +             +   +   +       
S.No. age sex CXR1 CXR2 L.V.H ECHO-
NSF 
MILD MOD Severe DDF1 DDF2 DDF3 
H/O 
Stroke 
Rec. 
HP 
Dense 
HP 
Alt. 
Sens 
CT 
- N 
Lac. 
Infr 
Mass 
Infr 
MORT 
22 64 M     + +               +       +     
23 80 M       +               +     +       
24 40 M     + +             + +       +     
25 45 M       +               +             
26 41 M       +                 +     +     
27 60 M     + +             +   +           
28 50 M           +         + +     +       
29 52 M       +               +     +       
30 52 M       +               +       +     
31 72 M       +             +   +       +   
32 42 M   + + +             +     + +       
33 80 F     + +                 +       +   
34 70 F     + +               +     +       
35 51 F     + +               +     +       
36 75 F       +                 +   +       
37 63 F     + +               +     +       
38 48 F     + +             + +       +     
39 80 F       +               +     +       
40 68 F   + +   +             +       +     
41 70 F   + + +                 +   +       
42 56 F       +             +   +     +     
43 69 F     + +               +       +     
S.No. age sex CXR1 CXR2 L.V.H ECHO-
NSF 
MILD MOD Severe DDF1 DDF2 DDF3 
H/O 
Stroke 
Rec. 
HP 
Dense 
HP 
Alt. 
Sens 
CT 
- N 
Lac. 
Infr 
Mass 
Infr 
MORT 
44 45 F     + +       +       +     +       
45 70 F   + + +               +     +       
46 80 F       +               +       +     
47 45 F       +                 +       +   
48 68 F       +             +     +     +   
49 80 F     + +             + +     +       
50 65 F       +                 +       +   
51 55 F       +               +     +       
52 50 F       +               +     +       
53 63 F       +                 +   +       
54 65 F +     +             +   +   +       
55 50 F     +   +             +     +       
56 65 F     + +               +       +     
57 43 F     + +               +       +     
58 50 F         +           +   +   +       
59 55 F         +             +       +     
60 55 F       +               +     +       
61 48 F         +             +     +       
62 55 F   +   +                 +     +   + 
63 75 F     + +                 +   +       
64 70 F     + +               +     +       
65 55 F     + +               +       +   + 
S.No. age sex CXR1 CXR2 L.V.H ECHO-
NSF 
MILD MOD Severe DDF1 DDF2 DDF3 
H/O 
Stroke 
Rec. 
HP 
Dense 
HP 
Alt. 
Sens 
CT 
- N 
Lac. 
Infr 
Mass 
Infr 
MORT 
66 43 F       +               +     +       
67 58 F   +       +   +       +     +       
68 70 F   +     +               +       + + 
69 50 F   + + +       +     + +       +     
70 45 F     + +               +       +     
71 62 F   + + +               +     +       
72 54 F   +         +           +       + + 
73 70 F     + +               +       +     
74 66 F   + + +                 +   +       
75 50 F           +             +       +   
76 65 F     +   +           + +       +     
77 70 F           +             +       +   
78 65 F +   +   +             +     +       
79 39 F       +       +       +       +     
80 57 F     +           +       +       +   
81 75 M     + +             +   +       +   
82 75 M   +         +           +       +   
83 60 M       +                   +     +   
84 60 M       +             +   +       +   
85 90 M   + +   +             +       +     
86 42 M       +             + +       +     
87 64 M     + +               +       +     
S.No. age sex CXR1 CXR2 L.V.H ECHO-
NSF 
MILD MOD Severe DDF1 DDF2 DDF3 
H/O 
Stroke 
Rec. 
HP 
Dense 
HP 
Alt. 
Sens 
CT 
- N 
Lac. 
Infr 
Mass 
Infr 
MORT 
88 72 M     +   +           +   +       +   
89 84 M       +             +   +       +   
90 58 M       +               +       +     
91 52 M     + +               +     +       
92 72 M   +   +             +   +       + + 
93 48 M     + +                 +       + + 
94 55 M     + +             +   +       +   
95 52 M     + +               +     +       
96 65 M     + +               +     +       
97 40 M +   + +       +     +   +       +   
98 62 M       +             +   +       +   
99 88 M       +             +   +       +   
100 45 M       +                 +       +   
101 54 M       +             +     +     +   
102 48 M     + +             +     +     +   
103 56 M     + +               +       +     
104 75 M       +         +   +     +     + + 
105 65 M       +                             
106 50 M   + + +       +     +     +     +   
107 70 M     + +                 +       + + 
108 63 M       +                 +       +   
109 74 M       +                   +     +   
S.No. age sex CXR1 CXR2 L.V.H ECHO-
NSF 
MILD MOD Severe DDF1 DDF2 DDF3 
H/O 
Stroke 
Rec. 
HP 
Dense 
HP 
Alt. 
Sens 
CT 
- N 
Lac. 
Infr 
Mass 
Infr 
MORT 
110 52 M       +                 +       +   
111 62 M +     +               +     +       
112 70 M     + +               +       +     
113 43 M       +               +     +       
114 51 M     + +                   +     +   
115 60 M       +                 +       +   
116 82 M       +       +           +     + + 
117 50 M   +       +         +     +     +   
118 59 M   +       +         +     +     +   
119 48 M       +             + +       +     
120 42 M     + +       +     +     +     +   
121 45 M         +             +       +     
122 42 M       +               +       +     
123 66 M     + +             +     +     +   
124 69 M   +         +             +     +   
125 78 M           +             + +     +   
126 53 M       +       +           +     +   
127 80 M   + +     +             +       +   
128 66 M     + +               +       +     
129 60 M     + +               +       +     
130 40 M     + +                 +       +   
131 47 M       +                 +     +     
S.No. age sex CXR1 CXR2 L.V.H ECHO-
NSF 
MILD MOD Severe DDF1 DDF2 DDF3 
H/O 
Stroke 
Rec. 
HP 
Dense 
HP 
Alt. 
Sens 
CT 
- N 
Lac. 
Infr 
Mass 
Infr 
MORT 
132 80 M   +     +                 +     +   
133 60 M     + +               +       +     
134 56 M     + +               +       +     
135 60 M     +   +           +     +     +   
136 64 M   +         +             +     +   
137 55 M     + +             +     +     +   
138 60 M   +         +       +     +     +   
139 70 M     + +               +       +     
140 75 M     +     +             +       +   
141 62 M     + +             + +       +     
142 55 M   + + +             +     +     +   
 
CXR1  - Pulmonary Venous congestion           CXR2 – Cardiomegaly     LVH – LVH in Echo       Echo NSF – Normal Systolic Function 
MILD – Mild LVSD          MOD – Moderate LVSD        Severe – Severe LVSD    DDF  -  Diastolic Dysfunction        
Rec HP - Recovering hemiparesis         Dense HP - Dense hemiplegia       CT N - CT normal     Lac. Infr - Lacunar infarct 
MASS. Infr - Massive Infarct        MORT -  Mortality 
